In this episode, our expert speakers explain how to create eLearning resources that are relevant, credible and evidence-based.
In this episode, Ariel Katz, co-Founder and CEO of H1, provides a more linear and streamlined vision for how Medical Affairs can impact patient outcomes — and how to measure the results of our actions.
MAPS announces the election of Dr. Danie du Plessis as Chair of the MAPS Board of Directors. Du Plessis is currently Executive Vice-President (EVP) & Head of Medical Affairs at Kyowa Kirin International and is a senior pharmaceutical executive with 30 years’ experience.
This White Paper draws on the expertise of 10 senior Medical Affairs leaders across diverse global organizations to describe the role of Medical Affairs in ensuring the MedTech industry meets the challenges of high-quality evidence, objective measures, changes in the healthcare landscape, and more.
In this episode, we hear from RWE and industry experts on the importance of early alignment of your evidence generation plan and medical strategy and how to integrate RWE into your publication plan.
By using the framework of Explore, Educate, Embrace we can shape our approach to Health Equity by incorporating it into our daily work.
In this article and accompanying mAPS 2023 Annual Meeting workshop, we will explore the benefits of using a competency model for employees and employers and how employers can implement a competency model within their organizations.
In today’s episode, we speak with Chris Medieros about how to maximize your organization’s presence and impact at congresses.
In today’s episode, we’ll be looking at considerations for Medical Affairs in Rare Disease and Gene Therapy
Streamlining the diagnostic odyssey requires educating medical professionals to recognize “rare encounters” and engage these patients with precision and compassion.